| Hepatitis B e antigen–negative chronic hepatitis B SJ Hadziyannis, D Vassilopoulos Hepatology 34 (4), 617-624, 2001 | 848 | 2001 |
| Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir SJ Hadziyannis, V Sevastianos, I Rapti, D Vassilopoulos, E Hadziyannis Gastroenterology 143 (3), 629-636. e1, 2012 | 394 | 2012 |
| EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update B Hellmich, B Sanchez-Alamo, JH Schirmer, A Berti, D Blockmans, ... Annals of the Rheumatic Diseases 83 (1), 30-47, 2024 | 309 | 2024 |
| Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies LH Calabrese, NN Zein, D Vassilopoulos Annals of the rheumatic diseases 65 (8), 983-989, 2006 | 295 | 2006 |
| Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection LH Calabrese, N Zein, D Vassilopoulos Annals of the rheumatic diseases 63 (suppl 2), ii18-ii24, 2004 | 290 | 2004 |
| Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote … K Kambas, A Chrysanthopoulou, D Vassilopoulos, E Apostolidou, ... Annals of the rheumatic diseases 73 (10), 1854-1863, 2014 | 287 | 2014 |
| Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance … JA Sparks, ZS Wallace, AM Seet, MA Gianfrancesco, Z Izadi, KL Hyrich, ... Annals of the rheumatic diseases 80 (9), 1137-1146, 2021 | 234 | 2021 |
| TCR/CD3 complex-mediated signal transduction pathway in T cells and T cell lines from patients with systemic lupus erythematosus. D Vassilopoulos, B Kovacs, GC Tsokos Journal of immunology (Baltimore, Md.: 1950) 155 (4), 2269-2281, 1995 | 204 | 1995 |
| Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection D Vassilopoulos, A Apostolopoulou, E Hadziyannis, GV Papatheodoridis, ... Annals of the rheumatic diseases 69 (7), 1352-1355, 2010 | 183 | 2010 |
| Nailfold videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis: a multicenter, prospective cohort study M Cutolo, AL Herrick, O Distler, MO Becker, E Beltran, P Carpentier, ... Arthritis & rheumatology 68 (10), 2527-2539, 2016 | 168 | 2016 |
| Musculoskeletal infections in patients with human immunodeficiency virus infection D Vassilopoulos, P Chalasani, RL Jurado, K Workowski, CA Agudelo Medicine 76 (4), 284-294, 1997 | 161 | 1997 |
| An emerging role of neutrophils and NETosis in chronic inflammation and fibrosis in systemic lupus erythematosus (SLE) and ANCA-associated vasculitides (AAV): Implications for … E Frangou, D Vassilopoulos, J Boletis, DT Boumpas Autoimmunity reviews 18 (8), 751-760, 2019 | 155 | 2019 |
| Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies D Vassilopoulos, LH Calabrese Arthritis & Rheumatism 46 (3), 585-597, 2002 | 143 | 2002 |
| Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: the IRAP (International Registry of Anakinra for Pericarditis) study M Imazio, A Andreis, GM De Ferrari, PC Cremer, V Mardigyan, ... European journal of preventive cardiology 27 (9), 956-964, 2020 | 141 | 2020 |
| Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: role of decreased intracellular TNF-α B Kovacs, D Vassilopoulos, SA Vogelgesang, GC Tsokos Clinical immunology and immunopathology 81 (3), 293-302, 1996 | 139 | 1996 |
| Treatment of HBeAg-negative chronic hepatitis B SJ Hadziyannis, GV Papatheodoridis, D Vassilopoulos Seminars in liver disease 23 (01), 081-088, 2003 | 121 | 2003 |
| Tregs restrain dendritic cell autophagy to ameliorate autoimmunity T Alissafi, A Banos, L Boon, T Sparwasser, A Ghigo, K Wing, ... The Journal of clinical investigation 127 (7), 2789-2804, 2017 | 113 | 2017 |
| Validation of the classification criteria for cryoglobulinaemic vasculitis L Quartuccio, M Isola, L Corazza, M Ramos-Casals, S Retamozo, ... Rheumatology 53 (12), 2209-2213, 2014 | 110 | 2014 |
| Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations D Vassilopoulos, LH Calabrese Arthritis research & therapy 10, 1-8, 2008 | 110 | 2008 |
| Risks of immunosuppressive therapies including biologic agents in patients with rheumatic diseases and co-existing chronic viral infections D Vassilopoulos, LH Calabrese Current opinion in rheumatology 19 (6), 619-625, 2007 | 105 | 2007 |
